- Affordability (20%)
- Patient does not feel they need the medication (20%)
- Side effects (17%)
- Forgetfulness (16%)
- Lack of concern for their condition (5%)
- Lack of information on disease or treatment (5%)
- Lack of information on the drug they are prescribed (5%)
- Lack of family/social support (5%)
- Low satisfaction with the drug they are prescribed (3%)
- Poor relationship with myself or another physician (2%)
- Patient received prior recommendation against the drug either by another health professional or patient (2%).
Two-thirds of physicians believe that they have the most influence of whether patients take medications as prescribed; 30% believe that the caregivers have more influence. 6% believe it’s the health plan that wields the most influence over prescription adherence.
If you think patients are dissing prescriptions only for asymptomatic conditions like high blood pressure, you’re dead wrong.
The Rx “affordability” hurdle is demonstrated by new data released by Thomson Reuters, which has found that some cancer patients avoid treatment due to cost. According to Thomson, 25% of patients with late-stage cancer whose incomes are under $40,000 choose not to undergo recommended care.
In their report, The Cost of Cancer, Thomson analyzes 1,767 survey responses completed by cancer patients. Thomson identifies what they term “a clear link” between income and the acquisition of cancer treatment.
The difference between patients of varying income levels is striking: overall, 12.3% of late-stage cancer patients refuse cancer treatment due to its expense. By income level:
- 25% of late-stage cancer patients who earn less than $40,000 a year choose not to undergo a recommended treatment due to cost
- 11% of those earning between $40,000 and $80,000 per year refuse treatment
- 5% those earning more than $80,000 annually refuse treatment for cancer.